EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Carter Bank and Trust (CARE) fair value: what the stock is really worth

As of Sep 23, 2026: fair value of Carter Bank and Trust $21.11, price $29.93, upside -29.5%, quality 60 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? No
  2. Good quality? Yes
  3. Add to watchlist

Financial Services · US · ISIN US1461031064

CB Carter Bank and Trust logo Broad data Sep 23, 2026

Carter Bank and Trust

CARE · US

Overvalued / MonitorQuality is not strong enough to offset the price risk.

!Fair value $21.11 · Overvalued (−29%)
!Quality 60/100
✓Healthy Growth (revenue 5y +9.2 %/yr)
✓Highly profitable · 41.8% net margin (TTM)
✓Low debt · generates free cash flow
!Mixed vs. peers (8/14)
✓Wide moat 76/100
Watch Carter Bank and Trust for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free Pro now: $1 first month

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$35.72 $10.11 Fair Value $21.11 Jun 2021 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 23, 2026.

How to read this chart

60‑month range $10.11 – $35.72 · fair‑value band $15.83 – $26.39 · the $29.93 price screens above the $21.11 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 1 fiscal year is left out: there the valuation rested on only a fraction of the usual models. Dashed = 300-day average. As of Sep 23, 2026.

Follow Carter Bank and Trust in your weekly email

Every Wednesday you see whether Carter Bank and Trust is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Carter Bankshares, Inc. operates as the bank holding company for Carter Bank & Trust that provides various retail and commercial banking products and insurance services in the United States. It offers various deposit products, including checking, savings, retirement, and money market accounts, as well as certificates of deposit.

Show more

Carter Bankshares, Inc. operates as the bank holding company for Carter Bank & Trust that provides various retail and commercial banking products and insurance services in the United States. It offers various deposit products, including checking, savings, retirement, and money market accounts, as well as certificates of deposit. The company also provides commercial loans, such as secured and unsecured, real estate construction and acquisition, and commercial and industrial loans; consumer loans, such as automobiles, home improvements, education, overdraft protection, and personal, and residential mortgages loans; home equity lines of credit; and credit cards, as well as originates and holds fixed and variable rate mortgage loans. In addition, it offers other banking services that include safe deposit boxes, direct deposit of payroll, social security checks, and debit cards; online banking products, including online and mobile banking, online account opening, bill payment, electronic statement, mobile deposit, Zelle, credit monitoring tools, digital wallet, MoneyPass, and ATM services; title insurance and other financial institution-related products and services; and treasury and corporate cash management services. Carter Bankshares, Inc. was founded in 1974 and is headquartered in Martinsville, Virginia.

Stock analysis

Carter Bank and Trust (CARE) currently trades at $29.93, while our model-based Fair Value estimate is $21.11, implying the stock looks roughly 41.8% overvalued today.

Show more

Valuation

Bull case: the Multiples group reads highest at a median of $18.35 per share, and 0 of the 4 models we run sit above the $29.93 price.

Bear case: the Asset-Based group reads lowest at $12.65, and 4 of the 4 models stay below the price. Evidence for this calculation is high.

Scenario range: $15.83 (bear) to $26.39 (bull), the price of $29.93 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 60/100 (solid quality), in the Financial Services sector.

Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.

Carter Bank and Trust reported revenue of $255M in FY2025 versus $156M in FY2021, a compound +13.0%/yr. Reported net income was $31.4M in FY2025, compounding −0.2%/yr from FY2021.

Key figures

Market cap $672M · P/E ratio 6.1 · P/S ratio 0.76 · EPS (TTM) $4.87 · Net margin 12.3% · Return on equity 23.9% · Return on assets (EBIT) 0.9% · Operating margin 79.1%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 47 out of 100 (low confidence).

What moves the price

The share trades about 16% below its 52-week high and 77% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Financial Services peers we cover trades at −38% fair-value upside, at −29%, CARE screens cheaper than that median.

Fair Value models

Bear $15.83 Fair Value $21.11 Bull $26.39
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then ($3.56 per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
Residual Income $14.57 $15.10 $15.40 71
P/E Multiple $13.76 $18.35 $22.93 63
P/B Multiple $17.99 $23.99 $29.99 55
All 4 models by family
Multiples
P/E Multiple $13.76 $18.35 $22.93 63
P/B Multiple $17.99 $23.99 $29.99 55
Asset-Based
NCAV (Graham) $9.44 $12.65 $18.89 54
Economic Profit
Residual Income $14.57 $15.10 $15.40 71

Open the full fair value analysis →

Notify me when CARE reaches fair value

Put CARE on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 60/100

Of which business quality 49 · Market factors (momentum, volatility) 80

Profitability 24
Margins and returns on capital today
Quality Growth 62
Are margins and returns improving?
Cashflow 61
Earnings quality: real cash, not paper profit
Fin. Strength 7
Balance sheet, leverage, solvency risk
Investment 76
Disciplined investing over empire-building
Low Volatility 84
Calm price path (market factor)
Momentum 78
Price trend over the last 3–12 months (market factor)
52W Momentum 81
Distance to the 52-week high (market factor)
Net Issuance 100
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 89/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Revenue growth 1 year
+6.2%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+12.4%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+9.2%
Start year 2020 (pandemic). Over 10 years: +4.5% a year
Revenue growth 19 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+13.9%
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
+4.8%
Earnings growth per share plus dividend.
Earnings per share, growth per year+4.8%
Dividend (yield on the price)0.0%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.5% vs 1%, picking up
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.−28% → 16%
Start year 2020 (pandemic)

Growth Forecast

Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−0.1%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (USA: IMF forecast 2.4% a year to 2030, 3.1% from 2016 to 2025) that is about −2.5% a year for the price.

CARE screens 42% overvalued. Compare with DBS Group →

Compare Carter Bank and Trust with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Banks - Regional · 1074 stocks

Beats the industry median on 8/14 measures
A mixed picture versus its industry peers.
Valuation
Quality Score 58 · Above median
Fair Value upside −30% · Below median
Profitability
Return on equity (TTM) 24% · Top 25%
Return on assets 2% · Top 25%
Net margin (TTM) 42% · Top 25%
Operating margin (TTM) 79% · Top 25%
Growth and dividend
Revenue growth 260% · Top 25%
Dividend yield (TTM) 0.0% · Bottom 25%
Balance sheet
Debt / equity 0.43× · Above median

Valuation Multiplesvs Banks - Regional median · lower = cheaper

P/E (TTM) 6.1× · Cheapest 25%
P/B 1.60× · Priciest 25%
P/S (TTM) 2.60× · Cheaper than median
P/FCF 21.1× · Priciest 25%
EV/EBITDA 15.6× · Priciest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 11
FUTURE (revenue growth)100 · sector 45
PAST (return on equity)95 · sector 41
HEALTH (low debt)79 · sector 85
DIVIDEND (yield)0 · sector 53

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Banks - Regional stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
DBS Group D05 77.69 SGD 40.48 SGD −48%
China Merchants Bank Co 3968 HK$51.25 HK$62.30 +22%
Intesa Sanpaolo S.p.A ISP €6.73 €4.04 −40%
HDFC Bank Limited HDFCBANK ₹737.25 ₹406.85 −45%
BNP Paribas SA BNP €101.30 €105.99 +5%
UniCredit S.p.A UCG €83.28 €77.62 −7%
Mizuho Financial Group MFG $10.87 $6.75 −38%
ICICI Bank Limited ICICIBANK ₹1,340 ₹616.16 −54%
The PNC Financial Services Group PNC $227.96 $159.52 −30%
Oversea-Chinese Banking Corporation O39 32.14 SGD 19.80 SGD −38%

Explore undervalued stocks

More undervalued Financial Services stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Calculator with industry benchmark Peter Lynch Fair Value Formula &…Calculator with industry benchmark
Run the numbers yourself: free valuation calculators
DCF CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorFama-French ModelIntrinsic Value
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Carter Bank and Trust · Fair Value
$21.11 −42%Fair Value
Calculator →

Cite: Fair Value Calculator (2026). "Carter Bank and Trust Fair Value". https://www.fairvalue-calculator.com/stock/CARE

Frequently asked questions

Is Carter Bank and Trust (CARE) overvalued or undervalued?
As of Sep 23, 2026, our model estimates a fair value of $21.11 versus a price of $29.93, about −29% upside (overvalued).
What is the fair value of CARE?
Our model-based fair value for Carter Bank and Trust is $21.11 (as of Sep 23, 2026), built from audited fundamentals. The current price: $29.93.
What is the quality score of CARE?
Carter Bank and Trust has a Quality Score of 60/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Carter Bank and Trust (CARE)?
Our model-based price target is the fair value of $21.11 (as of Sep 23, 2026) from 4 valuation models. Cautious scenario $15.83, optimistic scenario $26.39. It is a calculation from audited fundamentals, not an analyst target.
What is the Carter Bank and Trust stock forecast for 2026?
Our models put fair value at $21.11, about −29% upside versus a price of $29.93 (overvalued). Cautious scenario $15.83, optimistic scenario $26.39. The calculation is refreshed regularly with new filings.
What is the revenue of Carter Bank and Trust (CARE)?
Carter Bank and Trust reported trailing-twelve-month revenue of about $259M (latest available figure, as of Sep 23, 2026).
What growth is priced into Carter Bank and Trust (CARE)?
For today's price to be fair in a discounted-cash-flow model, Carter Bank and Trust would have to grow free cash flow by -0.1 % per year for five years (discount rate 10.0 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +9.2 % per year. As of Sep 23, 2026.
What discount rate (WACC) does the fair value of CARE use?
Our models discount Carter Bank and Trust at 10.0 %: a base by market capitalisation (small), damped by beta 0.55, country premium for USA. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Carter Bank and Trust that is -0.1 % per year a year over ten years, using the same discount rate (10.0 %) and the same formula as our fair value.
How much growth has Carter Bank and Trust (CARE) delivered so far?
Over the past 5 years revenue at Carter Bank and Trust grew +9.2 % a year. The price currently implies -0.1 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Carter Bank and Trust (CARE) growing?
The median revenue growth in the sector is +8.4 % a year. That is the yardstick for the growth priced into Carter Bank and Trust (-0.1 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Carter Bank and Trust (CARE)?
The free-cash-flow yield on the price is 4.73 %: that much free cash flow Carter Bank and Trust produces per unit of market value. When it exceeds the discount rate of our models (10.0 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Carter Bank and Trust (CARE)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Carter Bank and Trust it is $21.11 per share (as of Sep 23, 2026), against a price of $29.93. It is the blended result of 4 valuation models (cash flow, earnings, asset, dividend).
Is Carter Bank and Trust stock overvalued or undervalued in 2026?
As of Sep 23, 2026, CARE trades above its calculated fair value: price $29.93, fair value $21.11, a gap of about −29% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of CARE?
No. The price is what the market pays today ($29.93); the fair value is what the company's own numbers justify ($21.11). For Carter Bank and Trust the two are $8.82 per share apart. That gap is exactly why we show both numbers side by side.
How much is Carter Bank and Trust worth?
The market values Carter Bank and Trust at about $672M (market capitalisation, as of Sep 23, 2026). Per share that is $29.93; our models calculate a fair value of $21.11 per share.
What do the bullish and bearish scenarios say about CARE?
Our models span a range for Carter Bank and Trust: cautious scenario $15.83, base $21.11, optimistic $26.39 per share (as of Sep 23, 2026, price $29.93). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of CARE?
Carter Bank and Trust trades at a price-to-earnings ratio of 6.1 (as of Sep 23, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of $21.11 is built from several models across several years. Other multiples: P/B 1.6, P/S 2.6, EV/EBITDA 15.6.
How solid is the balance sheet of Carter Bank and Trust (CARE)?
Balance-sheet figures for Carter Bank and Trust (as of Sep 23, 2026): return on equity 23.9%, debt of 0.43 per unit of equity. They feed the Quality Score of 60/100, which measures business quality independently of the share price.
How far is CARE from its 52-week high?
Carter Bank and Trust trades at $29.93, about 16% below its 52-week high of $35.72 and 77% above the low of $16.90 (as of Sep 23, 2026). Distance from the high says nothing about value: that is what the fair value of $21.11 is for.
Which stocks are comparable to Carter Bank and Trust?
From the same area (Financial Services) we also value DBS Group, China Merchants Bank Co, Intesa Sanpaolo S.p.A, HDFC Bank Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Carter Bank and Trust stock attractive at the current price?
The data as of Sep 23, 2026: price $29.93, calculated fair value $21.11 (−29%), Quality Score 60/100, from 4 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of CARE calculated?
We run Carter Bank and Trust through 4 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $21.11, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.1 % above its aggregate fair value. Carter Bank and Trust itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Carter Bank and Trust (CARE)?
The closing price on Sep 23, 2026 was $29.93. Our model-based fair value is $21.11, about −29% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Carter Bank and Trust right now?
The price sits above even our optimistic bull case ($26.39). The favourable scenario is already priced in. Solid but not exceptional quality (60/100) and above fair value, neither a clear bargain nor a standout compounder. For a financial, book-value and earnings-based methods matter more than a cash-flow DCF, which fits banks and insurers poorly.
Where does the earnings growth of Carter Bank and Trust (CARE) come from?
Earnings per share at Carter Bank and Trust grew +0.2 % a year from 2014 to 2025. Broken into its drivers: revenue per share +6.2 %, EBIT margin −5.5 %, tax rate −0.1 %, residual (interest, one-offs) +0.0 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.

Key figures of Carter Bank and Trust

How large is the market capitalisation of Carter Bank and Trust (CARE)?
The market capitalisation of Carter Bank and Trust is $672M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Carter Bank and Trust (CARE)?
The price-to-sales ratio of Carter Bank and Trust is 0.76 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Carter Bank and Trust (CARE)?
Earnings per share at Carter Bank and Trust are $4.87 (price ÷ EPS = P/E 6.1). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Carter Bank and Trust (CARE)?
The net margin of Carter Bank and Trust is 12.3% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Carter Bank and Trust (CARE)?
The return on equity (ROE) of Carter Bank and Trust is 23.9% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Carter Bank and Trust (CARE)?
On an EBIT basis the return on assets of Carter Bank and Trust is 0.9% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Carter Bank and Trust (CARE)?
The operating margin of Carter Bank and Trust is 79.1% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Carter Bank and Trust (CARE)?
Revenue at Carter Bank and Trust is growing +260% versus a year earlier (3y avg +12.4%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Carter Bank and Trust (CARE)?
Earnings per share at Carter Bank and Trust are growing +901% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Carter Bank and Trust (CARE) carry?
The net debt of Carter Bank and Trust is $73.3M (fiscal year 2025, ≈ 2.3 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Carter Bank and Trust in the live analysis

One click puts Carter Bank and Trust on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.